Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_04-cv-05429/USCOURTS-cand-4_04-cv-05429-51/pdf.json

Parties Involved:
Celtrix Pharmaceuticals, Inc.
Counter-claimant
Genentech, Inc.
Counter-defendant
Insmed Incorporated
Counter-claimant
Insmed Therapeutic Proteins
Defendant
Tercica, Inc.
Counter-defendant

Document Text:

MCDERMOTT WILL & EMERY LLP

ATTORNEYS AT LAW

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 117681-2.073241.0011

STIPULATION REGARDING PRELIMINARY

INSTRUCTIONS

CASE NO. C-04-5429 CW (EMC)

McDERMOTT WILL & EMERY LLP

WILLIAM G. GAEDE, III (136184)

wgaede@mwe.com

TERRENCE P. McMAHON (71910)

tmcmahon@mwe.com

ANDREW A. KUMAMOTO (178541)

akumamoto@mwe.com

DAVID L. LARSON (112342)

dlarson@mwe.com

3150 Porter Drive

Palo Alto, CA 94304-1212

Telephone: (650) 813-5000

Facsimile: (650) 813-5100

Attorneys for Tercica, Inc.

HELLER EHRMAN LLP

M. PATRICIA THAYER (90818)

patricia.thayer@hellerehrman.com

ETHAN C. GLASS (216159)

ethan.glass@hellerehrman.com

333 Bush Street

San Francisco, CA 94104-2878

Telephone: (415) 772-6794

Facsimile: (415) 772-6268

Attorneys for Genentech, Inc.

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

OAKLAND DIVISION

GENENTECH, INC., a Delaware

Corporation, TERCICA, INC., a Delaware

Corporation,

Plaintiffs,

v.

INSMED INCORPORATED, a Virginia

Corporation, and CELTRIX

PHARMACEUTICALS, INC., a Delaware

Corporation, INSMED THERAPEUTIC

PROTEINS, a Colorado Corporation,

Defendants.

No. C-04-5429 CW (EMC)

STIPULATION REGARDING

PRELIMINARY JURY INSTRUCTIONS

Trial Date: November 6, 2006

Hon. Claudia Wilken

AND RELATED COUNTERCLAIMS.

ORDER GRANTING

Case 4:04-cv-05429-CW Document 813 Filed 11/07/06 Page 1 of 3
MCDERMOTT WILL & EMERY LLP

ATTORNEYS AT LAW

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 117681-2.073241.0011 1

STIPULATION REGARDING PRELIMINARY

INSTRUCTIONS

CASE NO. C-04-5429 CW (EMC)

C N . C-04-5429 CW (EMC)

Based on recent rulings of the Court, and in an effort to streamline the trial, the parties

have reached further agreements regarding the ‘414 and ‘287 patents, and wish to amend the

Court’s Preliminary Jury Instructions accordingly. In particular, , the parties have agreed that: (1)

the parties will not ask the jury to determine infringement of claims 3 and 4 of the ‘414 patent

because the parties have stipulated to infringement of those claims (subject to Defendants’ right

to appeal); and (2) the parties will not ask the jury to determine any issue regarding claim 20 of

the ‘287 patent (subject to Plaintiffs’ right to appeal).

Accordingly, Genentech Inc. and Tercica, Inc. (“Plaintiffs”) and Insmed Incorporated,

Celtrix Pharmaceuticals, Inc and Insmed Therapeutics Proteins (“Defendants”), through their

respective counsel, agree to the following stipulations with respect to this Court’s Preliminary

Jury Instructions dated November 2, 2006:

Page 13, line 9: Change “claims 1, 6-8, 17 and 20” to “claims 1, 6-8, and 17”;

Page 13, line 171⁄2: Change “claims 1, 2, 9 and 10” to “claims 1-4 and 9-10”;

Page 14, line 2: Change “asserted claims of the ‘151, ‘287 and ‘414 patents” to “asserted

claims of the ‘151 and ‘287 patents”;

Page 14, lines 23-24: Delete “, and claims 3 and 4 of the ‘414 patent”; and

Page 21, lines 11-15: The first sentence of this paragraph shall be replaced with the

following two sentences: “Genentech will present its evidence on its contention that the asserted

claims of the ‘151 and ‘287 patents have been and continue to be infringed by Insmed.

Genentech also will present its evidence that infringement of the ‘151, ‘287 and ‘414 patents has

been and continues to be willful.”

For the convenience of the Court and before the trial starts, an electronic copy and a hard

copy of the revised Preliminary Jury Instructions incorporating the stipulated changes will be

delivered to the Court.

Case 4:04-cv-05429-CW Document 813 Filed 11/07/06 Page 2 of 3
MCDERMOTT WILL & EMERY LLP

ATTORNEYS AT LAW

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 117681-2.073241.0011 2

STIPULATION REGARDING PRELIMINARY

INSTRUCTIONS

CASE NO. C-04-5429 CW (EMC)

C N . C-04-5429 CW (EMC)

SO STIPULATED.

Dated: November 3, 2006 MCDERMOTT WILL & EMERY LLP

By: /s/ William G. Gaede, III

William G. Gaede, III

Attorneys for Tercica, Inc.

HELLER EHRMAN LLP

By: /s/ M. Patricia Thayer

M. Patricia Thayer

Attorneys for Genentech, Inc.

FOLEY & LARDNER, LLP

By: /s/ Rick Chang

Rick Chang

Attorneys for Insmed Incorporated, Celtrix

Pharmaceuticals, Inc., and Insmed

Therapeutic Proteins, Inc.

-oOoPURSUANT TO STIPULATION, IT IS SO ORDERED.

Dated:

HONORABLE CLAUDIA WILKEN

Judge of the United States District Court

11/7/06

Case 4:04-cv-05429-CW Document 813 Filed 11/07/06 Page 3 of 3